Literature DB >> 19538541

Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia.

Seyed-Moayed Alavian1, Seyyed Mohammad Miri, Maryam Keshvari, Pegah Karimi Elizee, Bita Behnava, Seyed-Vahid Tabatabaei, Kamran Bagheri Lankarani.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) infection is the most common transfusion-transmitted disease in multiply transfused patients worldwide. In this study, the aim was to investigate distribution of HCV genotypes in Iranian patients with thalassemia. STUDY DESIGN AND METHODS: Blood samples were received from 280 multiply transfused patients with thalassemia with chronic hepatitis C who were referred to us to start pegylated interferon-alpha plus ribavirin for duration of 48 weeks. HCV RNA viral load was detected using Amplicor test (Version 2, Roche Molecular Systems). Genotyping was performed by genotype-specific primers.
RESULTS: HCV genotype distribution was 1 in 57%, 3 in 35%, 2 in 1%, and mixed in 4% (1 + 3 in 2.8%, 3 + 4 in 0.4%, mixed subtypes in 0.8%) cases. A total of 2.5% of isolates were nontypable. Genotype 1 was associated with higher rate of splenectomy and greater serum ferritin.
CONCLUSION: Genotype 1 is the most frequently detected HCV genotype in Iranian patients with thalassemia and might cause more need for splenectomy and more severe iron overloading. Higher HCV viral load could be regarded as another risk factor for greater iron overloading.

Entities:  

Mesh:

Year:  2009        PMID: 19538541     DOI: 10.1111/j.1537-2995.2009.02252.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  21 in total

1.  Determination of hepatitis C genotypes and the viral titer distribution in children and adolescents with major thalassemia.

Authors:  Touran Shahraki; Mansour Shahraki; Esmaiel Sanei Moghaddam; Mehri Najafi; Ali Bahari
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

2.  Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy.

Authors:  Seyed Vahid Tabatabaei; Seyed Moayed Alavian; Maryam Keshvari; Bita Behnava; Seyyed Mohammad Miri; Pegah Karimi Elizee; Farhad Zamani; Sedigheh Amini Kafiabad; Ahmad Gharehbaghian; Bashir Hajibeigy; Kamran Bagheri Lankarani
Journal:  Hepat Mon       Date:  2012-06-30       Impact factor: 0.660

3.  HCV genotypes of people with hemophilia in countries with high seroprevalances.

Authors:  J N Mahlangu; N Prabdial-Sing
Journal:  Iran Red Crescent Med J       Date:  2011-02-01       Impact factor: 0.611

4.  Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin.

Authors:  Maryam Jafroodi; Ramin Asadi; Abtin Heydarzadeh; Sepiedeh Besharati
Journal:  Int J Gen Med       Date:  2011-07-13

5.  Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran.

Authors:  Seyedeh Farzaneh Mousavi; Seyed Hamid Moosavy; Seyed Moayed Alavian; Hajar Eghbali; Hamidreza Mahboobi
Journal:  Hepat Mon       Date:  2013-12-16       Impact factor: 0.660

6.  Real response to therapy in chronic hepatitis C virus patients: a study from iran.

Authors:  Najmeh Namazee; Shahnaz Sali; Sorour Asadi; Mostafa Shafiei; Bita Behnava; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2012-09-15       Impact factor: 0.660

7.  Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains.

Authors:  Katayoun Samimi-Rad; Freshteh Asgari; Mohsen Nasiritoosi; Abdoulreza Esteghamati; Azar Azarkeyvan; Seyedeh Masoomeh Eslami; Farhad Zamani; Lars Magnius; Seyed Moayed Alavian; Heléne Norder
Journal:  Hepat Mon       Date:  2013-01-23       Impact factor: 0.660

8.  High Rate of Virological Response to Peginterferon α-2a-Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C.

Authors:  Mostafa Alavi Moghaddam; Mohammad Reza Zali; Seyed Hossein Aalaei Andabili; Faramarz Derakhshan; Seyed Mohammad Miri; Seyed Moayed Alavian
Journal:  Iran Red Crescent Med J       Date:  2012-08-30       Impact factor: 0.611

9.  Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis.

Authors:  Mazaher Khodabandehloo; Daem Roshani; Kourosh Sayehmiri
Journal:  J Res Med Sci       Date:  2013-08       Impact factor: 1.852

10.  letter to Hajiani E, Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic Analysis of Hepatitis C Virus in Khuzestan Province, Southwestern Iran. Middle East J Dig Dis 2011;3:126-30.

Authors:  Seyed Moayed Alavian; Kamran Bagheri Ankarani
Journal:  Middle East J Dig Dis       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.